+499.5%
MRNA vs ACM
-45.8%
+545.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ACM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.4% | -1.9% | -1.9% |
| 7D | +5.5% | -3.7% | +9.2% | +8.6% |
| 30D | +158.7% | -11.1% | +169.8% | +155.3% |
| 3M | +182.1% | -8.0% | +190.1% | +175.6% |
| 6M | +151.8% | -29.7% | +181.5% | +168.5% |
| YTD | +393.6% | -29.4% | +422.9% | +417.1% |
| 1Y | +499.5% | -46.4% | +545.9% | +615.1% |
| All | +499.5% | -45.8% | +545.2% | +615.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ACM.
Daily Out/Under-Performance
Portfolio return minus ACM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ACM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ACM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling